BENEVICH ERIC bought NBIX
September 9, 2026 · Form 4 insider transaction
BENEVICH ERIC bought 3,194 shares of Neurocrine Biosciences, Inc. at $43.24 per share, a transaction worth $138.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,194
Price
$43.24
Total value
$138.1K
InsiderBENEVICH ERIC
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 9, 2026
Filing dateSeptember 10, 2026
Shares owned after66,562
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes an aggregate of 178 shares purchased on February 27, 2026 and August 31, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.